Oncternal Therapeutics Statistics
Total Valuation
LAMR has a market cap or net worth of $11.87 billion. The enterprise value is $16.52 billion.
Important Dates
The last earnings date was Friday, August 8, 2025, before market open.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
LAMR has 101.22 million shares outstanding. The number of shares has increased by 0.07% in one year.
Current Share Class | 86.80M |
Shares Outstanding | 101.22M |
Shares Change (YoY) | +0.07% |
Shares Change (QoQ) | -1.11% |
Owned by Insiders (%) | 6.04% |
Owned by Institutions (%) | 87.36% |
Float | 86.03M |
Valuation Ratios
The trailing PE ratio is 27.35 and the forward PE ratio is 19.95.
Price/FFO Ratio | 14.53 |
Price/AFFO Ratio | n/a |
PE Ratio | 27.35 |
Forward PE | 19.95 |
PS Ratio | 5.25 |
Forward PS | 6.80 |
PB Ratio | 12.86 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | 13.66 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 37.63 |
EV / Sales | 7.39 |
EV / EBITDA | 16.40 |
EV / EBIT | 30.54 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.58, with a Debt / Equity ratio of 5.26.
Current Ratio | 0.58 |
Quick Ratio | 0.51 |
Debt / Equity | 5.26 |
Debt / EBITDA | 3.39 |
Debt / FCF | n/a |
Interest Coverage | 3.34 |
Financial Efficiency
Return on equity (ROE) is 41.90% and return on invested capital (ROIC) is 5.87%.
Return on Equity (ROE) | 41.90% |
Return on Assets (ROA) | 5.10% |
Return on Invested Capital (ROIC) | 5.87% |
Return on Capital Employed (ROCE) | 9.18% |
Revenue Per Employee | $638,371 |
Profits Per Employee | $125,435 |
Employee Count | 3,500 |
Asset Turnover | 0.34 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, LAMR has paid $17.07 million in taxes.
Income Tax | 17.07M |
Effective Tax Rate | 3.73% |
Stock Price Statistics
The stock price has increased by +1.15% in the last 52 weeks. The beta is 1.39, so LAMR's price volatility has been higher than the market average.
Beta (5Y) | 1.39 |
52-Week Price Change | +1.15% |
50-Day Moving Average | 122.36 |
200-Day Moving Average | 122.12 |
Relative Strength Index (RSI) | 37.21 |
Average Volume (20 Days) | 552,705 |
Short Selling Information
The latest short interest is 5.13 million, so 5.07% of the outstanding shares have been sold short.
Short Interest | 5.13M |
Short Previous Month | 5.17M |
Short % of Shares Out | 5.07% |
Short % of Float | 5.96% |
Short Ratio (days to cover) | 8.99 |
Income Statement
In the last 12 months, LAMR had revenue of $2.23 billion and earned $439.02 million in profits. Earnings per share was $4.29.
Revenue | 2.23B |
Gross Profit | 1.50B |
Operating Income | 540.98M |
Pretax Income | 513.89M |
Net Income | 439.02M |
EBITDA | 1.01B |
EBIT | 540.98M |
Earnings Per Share (EPS) | $4.29 |
Full Income Statement Balance Sheet
The company has $55.73 million in cash and $4.77 billion in debt, giving a net cash position of -$4.72 billion or -$46.58 per share.
Cash & Cash Equivalents | 55.73M |
Total Debt | 4.77B |
Net Cash | -4.72B |
Net Cash Per Share | -$46.58 |
Equity (Book Value) | 906.88M |
Book Value Per Share | 8.94 |
Working Capital | -325.12M |
Full Balance Sheet Cash Flow
Operating Cash Flow | 863.94M |
Capital Expenditures | -109.02M |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 67.07%, with operating and profit margins of 24.21% and 19.67%.
Gross Margin | 67.07% |
Operating Margin | 24.21% |
Pretax Margin | 20.51% |
Profit Margin | 19.67% |
EBITDA Margin | 45.09% |
EBIT Margin | 24.21% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $6.20, which amounts to a dividend yield of 5.29%.
Dividend Per Share | $6.20 |
Dividend Yield | 5.29% |
Dividend Growth (YoY) | 20.59% |
Years of Dividend Growth | 1 |
Payout Ratio | 143.43% |
Buyback Yield | -0.07% |
Shareholder Yield | 5.28% |
Earnings Yield | 3.72% |
FCF Yield | n/a |
Dividend Details Analyst Forecast
The average price target for LAMR is $134.20, which is 14.43% higher than the current price. The consensus rating is "Buy".
Price Target | $134.20 |
Price Target Difference | 14.43% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside | |
Stock Splits
The last stock split was on March 2, 1998. It was a forward split with a ratio of 1.5:1.
Last Split Date | Mar 2, 1998 |
Split Type | Forward |
Split Ratio | 1.5:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 6 |